Clinical Trials Directory

Trials / Completed

CompletedNCT01652170

The Performance of the APPY1 Test in the Evaluation of Possible Acute Appendicitis

The Performance of the APPY1 Test in the Evaluation of Possible Acute Appendicitis in Children, Adolescents, and Young Adults Presenting to the Emergency Department

Status
Completed
Phase
Study type
Observational
Enrollment
2,201 (actual)
Sponsor
Venaxis, Inc. · Industry
Sex
All
Age
2 Years – 20 Years
Healthy volunteers
Not accepted

Summary

This study will consist of a brief interaction with the subject or parent or guardian to obtain consent, collect a blood sample, medical history, and physical examination of those who meet the inclusion criteria. The blood sample will be tested for the WBC value, as well as processed into plasma in order to compute the APPY1 Test result, which is based on a combination of the WBC value and the plasma MRP 8/14 and CRP concentrations received from the APPY1 Test cassette. There will be a 2-week (14 days +/- 3) follow-up telephone call for those subjects that were discharged from the ED without an appendectomy or diagnosis of acute appendicitis. Use of the APPY1 Test to help identify low risk patients could significantly reduce the use of CT scans in diagnosis of AA, thereby reducing the exposure to ionizing radiation in children, adolescents, and young adults.

Conditions

Timeline

Start date
2013-01-01
Primary completion
2014-02-01
Completion
2014-02-01
First posted
2012-07-27
Last updated
2014-03-24

Locations

29 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01652170. Inclusion in this directory is not an endorsement.

The Performance of the APPY1 Test in the Evaluation of Possible Acute Appendicitis (NCT01652170) · Clinical Trials Directory